According to the WHO, Cancer is a prominent cause of mortality worldwide, accounting for ~ 10 million fatalities at the end of 2020. The most common types of cancers include Lung, Breast, CNS, Leukemia, Colon, and Cervical Cancer. Early detection of cancer can decrease the death toll. According to the study, if the cancer is identified at its early stage, the death rate can be reduced to ~85%. In order to reduce the death toll, machine learning (ML) emerges as a significant solution. When it comes to cancer research with ML, biopsy and microarray data come into the front. The biopsy data is less useful as it excludes a patient’s genetic information. However, due to the genetic information, the microarray data emerges as a solution to detecting cancer disease. Dealing with microarray data also has some consequences, and high dimensionality is one of them. This article reports an ML-based ensemble model to tackle microarray data issues and provide an effective model for cancer detection. The reported model uses Minimum Redundancy Maximum Relevance (MRMR) as the feature selection algorithm. The Whale Optimization Algorithm (WOA) is implemented for the featured dataset to select the optimistic number of features without affecting microarray data relevance. Then, four ML-based classification models, including Support Vector Machine, Decision Tree, Multi-Layer Perceptron, and Random Forest, are applied as the base learners to make initial predictions. Finally, the voting ensemble technique is applied to the initial prediction to develop an ensemble model for cancer prediction. The proposed En-MinWhale model is evaluated over six different types of cancer microarray datasets, including Lung, Leukemia, Ovarian, CNS, Breast, and Colon Cancer. Finally, the performance of the proposed model is evaluated using 11 various evaluative parameters, including accuracy, precision, specificity, sensitivity, F-β score, etc. The En-MinWhale model shows 94.09%, 95.83%, 94.86%, 95.00%, 94.85%, and 96.77% accuracy for Lung, Leukemia, Ovarian, CNS, Breast, and Colon Cancer datasets, respectively, that outperforms other considered hybrid models and can help out the physicians in Cancer diagnosis.

Background: There are several antibiotic resistance genes (ARG) for the Escherichia coli (E. coli) bacteria that cause urinary tract infections (UTI), and it is therefore important to identify these ARG. Artificial Intelligence (AI) has been used previously in the field of gene expression data, but never adopted for the detection and classification of bacterial ARG. We hypothesize, if the data is correctly conferred, right features are selected, and Deep Learning (DL) classification models are optimized, then (i) non-linear DL models would perform better than Machine Learning (ML) models, (ii) leads to higher accuracy, (iii) can identify the hub genes, and, (iv) can identify gene pathways accurately. We have therefore designed aiGeneR, the first of its kind system that uses DL-based models to identify ARG in E. coli in gene expression data. Methodology: The aiGeneR consists of a tandem connection of quality control embedded with feature extraction and AI-based classification of ARG. We adopted a cross-validation approach to evaluate the performance of aiGeneR using accuracy, precision, recall, and F1-score. Further, we analyzed the effect of sample size ensuring generalization of models and compare against the power analysis. The aiGeneR was validated scientifically and biologically for hub genes and pathways. We benchmarked aiGeneR against two linear and two other non-linear AI models. Results: The aiGeneR identifies tetM (an ARG) and showed an accuracy of 93% with area under the curve (AUC) of 0.99 (p < 0.05). The mean accuracy of non-linear models was 22% higher compared to linear models. We scientifically and biologically validated the aiGeneR. Conclusions: aiGeneR successfully detected the E. coli genes validating our four hypotheses.

Background Differential diagnosis in radiology is a critical aspect of clinical decision-making. Radiologists in the early stages may find difficulties in listing the differential diagnosis from image patterns. In this context, the emergence of large language models (LLMs) has introduced new opportunities as these models have the capacity to access and contextualize extensive information from text-based input. Objective The objective of this study was to explore the utility of four LLMs—ChatGPT3.5, Google Bard, Microsoft Bing, and Perplexity—in providing most important differential diagnoses of cardiovascular and thoracic imaging patterns. Methods We selected 15 unique cardiovascular (n = 5) and thoracic (n = 10) imaging patterns. We asked each model to generate top 5 most important differential diagnoses for every pattern. Concurrently, a panel of two cardiothoracic radiologists independently identified top 5 differentials for each case and came to consensus when discrepancies occurred. We checked the concordance and acceptance of LLM-generated differentials with the consensus differential diagnosis. Categorical variables were compared by binomial, chi-squared, or Fisher's exact test. Results A total of 15 cases with five differentials generated a total of 75 items to analyze. The highest level of concordance was observed for diagnoses provided by Perplexity (66.67%), followed by ChatGPT (65.33%) and Bing (62.67%). The lowest score was for Bard with 45.33% of concordance with expert consensus. The acceptance rate was highest for Perplexity (90.67%), followed by Bing (89.33%) and ChatGPT (85.33%). The lowest acceptance rate was for Bard (69.33%). Conclusion Four LLMs—ChatGPT3.5, Google Bard, Microsoft Bing, and Perplexity—generated differential diagnoses had high level of acceptance but relatively lower concordance. There were significant differences in acceptance and concordance among the LLMs. Hence, it is important to carefully select the suitable model for usage in patient care or in medical education.

Background Artificial intelligence chatbots have demonstrated potential to enhance clinical decision-making and streamline health care workflows, potentially alleviating administrative burdens. However, the contribution of AI chatbots to radiologic decision-making for clinical scenarios remains insufficiently explored. This study evaluates the accuracy and reliability of four prominent Large Language Models (LLMs)—Microsoft Bing, Claude, ChatGPT 3.5, and Perplexity—in offering clinical decision support for initial imaging for suspected pulmonary embolism (PE). Methods Open-ended (OE) and select-all-that-apply (SATA) questions were crafted, covering four variants of case scenarios of PE in-line with the American College of Radiology Appropriateness Criteria. These questions were presented to the LLMs by three radiologists from diverse geographical regions and setups. The responses were evaluated based on established scoring criteria, with a maximum achievable score of 2 points for OE responses and 1 point for each correct answer in SATA questions. To enable comparative analysis, scores were normalized (score divided by the maximum achievable score). Result In OE questions, Perplexity achieved the highest accuracy (0.83), while Claude had the lowest (0.58), with Bing and ChatGPT each scoring 0.75. For SATA questions, Bing led with an accuracy of 0.96, Perplexity was the lowest at 0.56, and both Claude and ChatGPT scored 0.6. Overall, OE questions saw higher scores (0.73) compared to SATA (0.68). There is poor agreement among radiologists' scores for OE (Intraclass Correlation Coefficient [ICC] = −0.067, p = 0.54), while there is strong agreement for SATA (ICC = 0.875, p < 0.001). Conclusion The study revealed variations in accuracy across LLMs for both OE and SATA questions. Perplexity showed superior performance in OE questions, while Bing excelled in SATA questions. OE queries yielded better overall results. The current inconsistencies in LLM accuracy highlight the importance of further refinement before these tools can be reliably integrated into clinical practice, with a need for additional LLM fine-tuning and judicious selection by radiologists to achieve consistent and reliable support for decision-making.